Cargando…

Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study

OBJECTIVES: This study aimed to assess the efficacy of DA‐9701 on gastrointestinal symptom‐related quality of life in patients with Parkinson's disease on stable dopaminergic medications. METHODS: This multicenter, double‐blind, placebo‐controlled, phase 4 trial included a total of 144 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ji‐Hyun, Lee, Jee‐Young, Cho, Jin Whan, Koh, Seong‐Beom, Yang, Young Soon, Yoo, Dalla, Shin, Cheol‐Min, Kim, Hee Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754502/ https://www.ncbi.nlm.nih.gov/pubmed/32761955 http://dx.doi.org/10.1002/mds.28219

Ejemplares similares

The Evidence of DA-9701 on Bowel Motility
por: Wang, Mingjie, et al.
Publicado: (2017)

The Effect of DA-9701 in Opioid-induced Bowel Dysfunction of Guinea Pig
por: Hussain, Zahid, et al.
Publicado: (2016)

Effect of DA-9701, a Novel Prokinetic Agent, on Post-operative Ileus in Rats
por: Lee, Sang Pyo, et al.
Publicado: (2017)

Efficacy of DA-9701 (Motilitone) in Functional Dyspepsia Compared to Pantoprazole: A Multicenter, Randomized, Double-blind, Non-inferiority Study
por: Jung, Hye-Kyung, et al.
Publicado: (2016)

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of DA-9701 (Motilitone) in Patients With Constipation-type Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Pilot Study
por: Lee, Ju Yup, et al.
Publicado: (2022)

Effect of DA-9701 on the Gastrointestinal Motility in the Streptozotocin-Induced Diabetic Mice
por: Ha, Changyoon, et al.
Publicado: (2021)

Effect of DA-9701 on Gastric Motor Function Assessed by Magnetic Resonance Imaging in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Min, Yang Won, et al.
Publicado: (2015)

DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia
por: Kwon, Yong Sam, et al.
Publicado: (2013)

Effect of DA-9701 on Colorectal Distension-Induced Visceral Hypersensitivity in a Rat Model
por: Kim, Eun Ran, et al.
Publicado: (2014)

Effect of DA-9701 on the Normal Motility and Clonidine-induced Hypomotility of the Gastric Antrum in Rats
por: Kang, Je Wook, et al.
Publicado: (2016)

Nitrergic Pathway Is the Major Mechanism for the Effect of DA-9701 on the Rat Gastric Fundus Relaxation
por: Min, Yang Won, et al.
Publicado: (2014)

DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia
por: Jin, Mirim, et al.
Publicado: (2018)

The Effect of DA-9701 on 5-Hydroxytryptamine-Induced Contraction of Feline Esophageal Smooth Muscle Cells
por: Oh, Kyung Hoon, et al.
Publicado: (2014)

Effects of the New Prokinetic Agent DA-9701 Formulated With Corydalis Tuber and Pharbitis Seed in Patients With Minimal Change Esophagitis: A Bicenter, Randomized, Double Blind, Placebo-controlled Study
por: Park, Chan Hyuk, et al.
Publicado: (2014)

Randomized, Controlled, Multi-center Trial: Comparing the Safety and Efficacy of DA-9701 and Itopride Hydrochloride in Patients With Functional Dyspepsia
por: Choi, Myung-Gyu, et al.
Publicado: (2015)

The art of passing unnoticed: pathogenic fungi remain incognito thanks to EWCA effectors
por: Hammoudi, Valentin
Publicado: (2021)

Effects of DA-9701, a Novel Prokinetic Agent, on Phosphorylated Extracellular Signal-Regulated Kinase Expression in the Dorsal Root Ganglion and Spinal Cord Induced by Colorectal Distension in Rats
por: Lee, Sang Pyo, et al.
Publicado: (2014)

A Randomized, Double‐Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease
por: Rascol, Olivier, et al.
Publicado: (2022)

Effect of a New Prokinetic Agent DA-9701 Formulated with Corydalis Tuber and Pharbitidis Semen on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes
por: Ji, Hye Young, et al.
Publicado: (2012)

Rest Tremor Pattern Predicts DaTscan ( (123)I‐Ioflupane) Result in Tremulous Disorders
por: Quattrone, Andrea, et al.
Publicado: (2021)

Dietary Antioxidants and Risk of Parkinson's Disease in the Singapore Chinese Health Study
por: Ying, Ariel Fangting, et al.
Publicado: (2020)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Longitudinal Changes in Isolated Rapid Eye Movement Sleep Behavior Disorder‐Related Metabolic Pattern Expression
por: Kim, Ryul, et al.
Publicado: (2021)

Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics
por: Bandres‐Ciga, Sara
Publicado: (2022)

The Parkinson's Disease DNA Variant Browser
por: Kim, Jonggeol J., et al.
Publicado: (2021)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The Myelin‐Weighted Connectome in Parkinson's Disease
por: Boshkovski, Tommy, et al.
Publicado: (2021)

A Randomized, Placebo‐Controlled Crossover Study with Dipyridamole for Restless Legs Syndrome
por: Garcia‐Borreguero, Diego, et al.
Publicado: (2021)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

The Impact of Type 2 Diabetes in Parkinson's Disease
por: Athauda, Dilan, et al.
Publicado: (2022)

GP2: The Global Parkinson's Genetics Program
Publicado: (2021)

Efficacy of DA-5204 (Stillen 2X) for patients with gastroesophageal reflux disease: A randomized, double-blind, placebo-controlled pilot study
por: Cho, Jae Ho, et al.
Publicado: (2020)

Orthostatic Hypotension: A Prodromal Marker of Parkinson's Disease?
por: Dommershuijsen, Lisanne J., et al.
Publicado: (2020)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
por: Iwaki, Hirotaka, et al.
Publicado: (2021)

Neuroimaging in Glucocerebrosidase‐Associated Parkinsonism: A Systematic Review
por: Filippi, Massimo, et al.
Publicado: (2022)

A Multi‐Step Model of Parkinson's Disease Pathogenesis
por: Le Heron, Campbell, et al.
Publicado: (2021)

Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
por: Omer, Nurit, et al.
Publicado: (2021)

Geographic variation in caesarean delivery in India
por: Rodgers, Justin, et al.
Publicado: (2021)

Long‐Term Safety and Clinical Effects of Nilotinib in Parkinson's Disease
por: Pagan, Fernando L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8vpi53438bgrfpqbrj5api4ase